本文關(guān)鍵詞：某三級(jí)甲等醫(yī)院多重耐藥菌感染現(xiàn)狀研究　出處：《山東大學(xué)》2015年碩士論文　論文類(lèi)型：學(xué)位論文

  更多相關(guān)文章： 多重耐藥菌 科室分布 易感因素預(yù)測(cè) 耐藥趨勢(shì)

【摘要】：研究背景中國(guó)MRSA(耐甲氧西林金黃色葡萄球菌)監(jiān)測(cè)率達(dá)50%,在國(guó)際上排名居前；ESBL(產(chǎn)超廣譜β內(nèi)酰胺酶桿菌)、CRE(耐碳青酶烯類(lèi)腸桿科細(xì)菌)、MDRAB (多重耐藥鮑曼不動(dòng)桿菌)等在綜合性醫(yī)院檢出比例均較高。MRSA感染幾乎遍及全球,成為臨床上最常見(jiàn)的病原菌之一,與艾滋病、乙型肝炎一起被稱(chēng)為當(dāng)今世界三大感染頑疾。各類(lèi)抗菌藥物,尤其是廣譜抗菌藥物的廣泛使用,臨床細(xì)菌耐藥形式嚴(yán)峻,已成為國(guó)內(nèi)外醫(yī)藥界備受關(guān)注的問(wèn)題。為保障醫(yī)療安全,同時(shí)使醫(yī)務(wù)人員更好的了解多重耐藥菌的易感因素和耐藥趨勢(shì),及早采取合理治療及防控措施,提高醫(yī)療機(jī)構(gòu)診治水平和防控醫(yī)院感染,特作以下研究。研究目的1、探討多重耐藥菌易感因素與耐藥菌趨勢(shì)變化情況；2、根據(jù)易感因素及多重耐藥菌特點(diǎn),作出多重耐藥菌感染的預(yù)測(cè)；3、分析各種類(lèi)型多重耐藥菌的耐藥率,可為臨床醫(yī)生的經(jīng)驗(yàn)性治療提供依據(jù)；4、根據(jù)多重耐藥菌檢出來(lái)源,可采取相關(guān)控制措施予以阻斷,防止患者的交叉感染；5、通過(guò)對(duì)多重耐藥菌醫(yī)院感染病例分析,指導(dǎo)臨床醫(yī)務(wù)人員開(kāi)展治療、護(hù)理與防控工作。研究方法回顧性調(diào)查2013年-2014年蚌埠市第三人民醫(yī)院檢出的各種多重耐藥菌,并對(duì)患者的基礎(chǔ)資料、標(biāo)本來(lái)源、細(xì)菌藥敏試驗(yàn)結(jié)果等進(jìn)行統(tǒng)計(jì)分析。根據(jù)監(jiān)測(cè)結(jié)果,作出多重耐藥菌的科室分布與耐藥趨勢(shì)變化。通過(guò)對(duì)患者的基本情況進(jìn)行卡方檢驗(yàn),評(píng)價(jià)相關(guān)多重耐藥菌與年齡、性別、標(biāo)本來(lái)源的關(guān)系。分析多重耐藥菌的醫(yī)院感染病例可對(duì)醫(yī)院感染病例進(jìn)行有針對(duì)性的防控。根據(jù)相關(guān)文獻(xiàn)查閱、細(xì)菌學(xué)特點(diǎn)、科室分布以及相關(guān)檢驗(yàn)做多重耐藥菌的易感因素預(yù)測(cè),從而能使臨床醫(yī)生在初診病人時(shí),可及時(shí)考慮多重耐藥菌感染的可能性,及早合理選擇針對(duì)性的抗菌藥物治療。主要結(jié)果制定出多重耐藥菌科室分布圖及耐藥趨勢(shì)變化圖�？擅黠@得出多重耐藥菌分布以ICU、骨科、普通外科等科室為主,易感因素主要有年齡、侵襲性操作等。MRSA耐藥率在40%以上的有紅霉素、克林霉素、左氧氟沙星、四環(huán)素、利福平、慶大霉素；耐藥率在40%以下的有萬(wàn)古霉素、替考拉寧、復(fù)方新諾明。在臨床治療懷疑金黃色葡萄球菌感染時(shí)應(yīng)予以參考。ESBL大腸埃希菌耐藥率在40%以上的有慶大霉素、復(fù)方新諾明、環(huán)丙沙星：耐藥率在40%以下的有頭孢西丁、哌拉西林/他唑巴坦、美羅培南、亞胺培南、阿米卡星；其中,頭孢西丁耐藥率在30%至40%之間。ESBL大腸埃希菌檢出率較高的普通外科等科室,應(yīng)在使用抗菌藥物預(yù)防與治療時(shí)予以參考。ESBL肺炎克雷伯菌耐藥率與產(chǎn)ESBL大腸埃希菌相比較,對(duì)各種抗生素的耐藥率略低。產(chǎn)CRE肺炎克雷伯菌臨床檢出例數(shù)增長(zhǎng)較快,雖占比不高,但由于可能產(chǎn)KPC酶,針對(duì)此類(lèi)細(xì)菌應(yīng)予以密切關(guān)注,防止較多CRE病例出現(xiàn)。MDRAB對(duì)臨床多種常見(jiàn)抗菌藥物耐藥率均較高,屬泛耐藥鮑曼不動(dòng)桿菌,其在多重耐藥菌總量中構(gòu)成比較高,應(yīng)引起關(guān)注。針對(duì)患者入住ICU、年齡、送檢標(biāo)本以及慢性炎癥、抗菌藥物的選擇等均可作為多重耐藥菌感染的預(yù)測(cè)因素及標(biāo)準(zhǔn)。根據(jù)不同科室收治患者不同,臨床醫(yī)師可根據(jù)相關(guān)特點(diǎn),在患者考慮感染時(shí)作出相關(guān)預(yù)測(cè)。作為醫(yī)院感染管理控制部門(mén),應(yīng)嚴(yán)控檢出較多科室,并加強(qiáng)與微生物實(shí)驗(yàn)室聯(lián)系,提高感染暴發(fā)預(yù)警意識(shí),同時(shí)加強(qiáng)與幾個(gè)檢出較多的臨床科室建立重點(diǎn)聯(lián)系,對(duì)該類(lèi)細(xì)菌感染建議聯(lián)用抗菌藥物評(píng)價(jià)臨床效果。結(jié)論與建議多重耐藥菌檢出比例增高明顯,各科室均有分布,臨床醫(yī)師可結(jié)合患者原發(fā)病以及相關(guān)易感因素作出多重耐藥菌感染的預(yù)測(cè),從而能及時(shí)合理的選擇敏感抗菌藥物。多重耐藥菌的感染病例較多,不僅局限于醫(yī)院內(nèi),較多慢性炎癥患者在長(zhǎng)期廣泛使用抗菌藥物治療后極易產(chǎn)生細(xì)菌耐藥,導(dǎo)致多重耐藥菌的產(chǎn)生,多重耐藥菌的控制應(yīng)作為一項(xiàng)公共衛(wèi)生事件來(lái)予以干預(yù),納入相關(guān)重點(diǎn)疾病研究,從各個(gè)環(huán)節(jié)控制抗菌藥物的濫用,開(kāi)展醫(yī)院高發(fā)科室的去定植工作,從而有效遏制多重耐藥菌的產(chǎn)生。
[Abstract]:On the background of China MRSA (methicillin-resistant Staphylococcus aureus) monitoring rate of 50% in the international ranking; ESBL (ESBLs strains), CRE (carbapenem resistant Enterobacteriaceae), MDRAB (multi drug resistant Acinetobacter Bauman) in general the detection rate of hospital infection of.MRSA were higher in almost all over the world, become one of the most common pathogens in clinical and AIDS, hepatitis B is called the world's three ills. Infection of various antibacterial drugs, especially the widespread use of broad-spectrum antibiotics, clinical bacteria resistant forms of severe, has been paid much attention at home and abroad the medical profession. To ensure medical safety, and medical personnel to better understand the multiple drug-resistant bacteria susceptible factors and the trend of drug resistance, to take reasonable treatment and prevention and control measures as soon as possible, improve the level of diagnosis and treatment of medical institutions and hospital infection prevention and control, especially for The following research. Objective: 1, to investigate multiple drug-resistant bacteria susceptible to changes in trend factors and drug resistant bacteria; 2, and according to the characteristics of multi drug resistant bacteria susceptible factors, make a prediction of multi drug resistant bacteria infection; 3, analysis of drug resistance of multidrug resistant bacteria of various types, can provide the basis for the empirical treatment of clinicians; 4. According to the multi drug resistant bacteria source, can take control measures to block, to prevent cross infection of patients; 5, through the analysis of the cases of multi drug resistant bacteria infection in hospital, clinical medical personnel to carry out the treatment, nursing and Prevention and control work. All kinds of multi drug resistant bacteria research methods retrospective survey in 2013 in Bengbu Third People's Hospital during -2014 detection, and on the basis of data were collected from drug sensitivity test results were analyzed. According to the monitoring results of multi drug resistant bacteria distribution and drug resistance tendency of Department Change. Chi square test was carried out through the basic situation of patients, evaluation of multidrug-resistant bacteria with age, sex, relationship between the specimen source. Analysis of cases of nosocomial infection cases for targeted prevention and control of multidrug-resistant bacteria in hospital. According to the relevant literature, the characteristics of bacteria, distribution of departments and relevant test for multiple drug resistant bacteria susceptible factors, which can make the clinicians in the newly diagnosed patients, may consider the possibility of multi drug resistant bacteria infection in a timely manner, a reasonable choice for early antibiotic treatment. The main results and formulate of multiple drug resistant bacteria distribution and drug resistance of the department changes. The Department of orthopedics may appear out of multidrug resistant bacteria in ICU, general surgery department, the predisposing factors include age, invasive operation.MRSA resistance rate in more than 40% of the erythromycin, clindamycin, tetracycline and levofloxacin, Li Fuping, gentamicin; drug resistance rate of 40% or less are teicoplanin, vancomycin, cotrimoxazole. In the clinical treatment of suspected Staphylococcus aureus infection should be.ESBL reference Escherichia coli resistance rate in more than 40% of the gentamicin, cotrimoxazole, ciprofloxacin resistance rate below 40% of the cefoxitin, piperacillin / tazobactam, imipenem, meropenem, Amikacin; among them, cefoxitin was between 30% and 40%.ESBL of Escherichia coli was higher rate of general surgery department, drug prevention and treatment should be in use to refer to.ESBL Klebsiella pneumoniae compared with the rate of production the ESBL of Escherichia coli, resistant to various antibiotics was slightly low. CRE producing Klebsiella pneumoniae clinical detection the number of cases increased rapidly, although the proportion is not high, but due to the possibility of producing KPC enzyme, the bacteria should be. Cut to prevent more attention, CRE cases of.MDRAB antibiotics were higher in various clinical common genera of Pan drug resistant Acinetobacter Bauman, the multi drug resistant bacteria is higher in total, should be paid more attention. For patients in the ICU age, and the specimens of chronic inflammation, the choice of antibiotics could be used as prediction the factors of multi drug resistant bacteria infection and standard. According to the different departments from patients, clinicians can according to relevant characteristics, make relevant prediction in patients considered infection. As the management of hospital infection control department, should strictly control the detected more departments, and strengthen ties with the microbiology laboratory, improve the outbreak warning consciousness, and strengthen the establishment of key clinical contact the Department with a few more of this type of detection, bacterial infection suggest antibiotic clinical evaluation. The conclusion and suggestion of multiple drug resistant bacteria than Patients increased significantly, each department has distribution, clinicians can patients with primary disease and related risk factors to predict the multi drug resistant bacteria infection combined to timely and reasonable selection of sensitive antibiotics. Multi drug resistant bacteria infections are not only confined to the hospital, many patients with chronic inflammation prone to bacterial resistance in long term the use of antimicrobial drugs after treatment, resulting in multiple drug-resistant bacteria, control of multidrug-resistant bacteria should be used as a public health emergency to be included in the relevant research focus of disease intervention, from all aspects of control system, abuse of antibiotics, hospital departments to work in planting, in order to effectively curb the multidrug-resistant bacteria.

【學(xué)位授予單位】：山東大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：R446.5

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 秦媛怡;陳雪梅;魏立平;;下呼吸道鮑曼不動(dòng)桿菌感染的分布特點(diǎn)和耐藥性及多重耐藥菌的易感因素[J];廣東醫(yī)學(xué);2012年18期

2 晏群;李軍;李虹玲;鄔靖敏;鄒明祥;劉文恩;;2011年湘雅醫(yī)院臨床分離病原菌分布及耐藥性分析[J];中國(guó)病原生物學(xué)雜志;2012年07期

3 朱艷萍;;2012年我院臨床科室多重耐藥菌的分析及干預(yù)[J];中國(guó)當(dāng)代醫(yī)藥;2013年08期

4 岳博華;;多重耐藥菌管理聯(lián)席會(huì)在多重耐藥菌感染控制中的作用[J];中國(guó)當(dāng)代醫(yī)藥;2013年12期

5 孫建芝;封建凱;李杰;蘇維奇;;醫(yī)院內(nèi)感染多重耐藥銅綠假單胞菌耐藥性分析及預(yù)防對(duì)策[J];中國(guó)實(shí)驗(yàn)診斷學(xué);2013年08期

6 湯麗霞;韋中盛;龍顯科;王俊利;李江麗;陳文成;何思陸;何小群;;西南地區(qū)多重耐藥菌的感染預(yù)測(cè)因素研究[J];右江民族醫(yī)學(xué)院學(xué)報(bào);2014年01期

7 崔桂梅;祝哲敏;薛永朝;馬洪生;劉超;李艷;李彥改;;綜合性ICU院內(nèi)感染細(xì)菌的分布情況及合理使用抗生素前后多重耐藥菌變化情況[J];醫(yī)學(xué)綜述;2014年10期

8 王成軍;許勇;王林海;張樹(shù)平;;鮑氏不動(dòng)桿菌感染的臨床分布特征及耐藥性分析[J];中華醫(yī)院感染學(xué)雜志;2014年17期

，

本文編號(hào)：1408759